Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 793Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Servier Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS LD

Patent Number : 1341196

Filing Date : 1981-10-01

Strength per Unit : 2.5 mg / 0.625 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-06

Date Granted : 2001-03-06

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS LD

Patent Number : 2423825

Filing Date : 2003-04-03

Strength per Unit : 2.5 mg / 0.625 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-03

Date Granted : 2006-02-21

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS

Patent Number : 1341196

Filing Date : 1981-10-01

Strength per Unit : 5 mg / 1.25 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-06

Date Granted : 2001-03-06

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS

Patent Number : 2423825

Filing Date : 2003-04-03

Strength per Unit : 5 mg / 1.25 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-04-03

Date Granted : 2006-02-21

blank

05

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Erbumine, Indapamide

Brand Name : COVERSYL PLUS

Patent Number : 1341196

Filing Date : 1981-10-01

Strength per Unit : 4mg / 1.25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-06

Date Granted : 2001-03-06

blank

06

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Erbumine, Indapamide

Brand Name : COVERSYL PLUS LD

Patent Number : 1341196

Filing Date : 1981-10-01

Strength per Unit : 2mg / 0.625mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-06

Date Granted : 2001-03-06

blank

07

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS LD

Patent Number : 2644467

Filing Date : 2007-02-26

Strength per Unit : 2.5 mg / 0.625 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-02-26

Date Granted : 2011-07-26

blank

08

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS

Patent Number : 2644467

Filing Date : 2007-02-26

Strength per Unit : 5 mg / 1.25 mg

Dosage Form : Film Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-02-26

Date Granted : 2011-07-26

blank

09

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Erbumine, Indapamide

Brand Name : COVERSYL PLUS HD

Patent Number : 1341196

Filing Date : 1981-10-01

Strength per Unit : 8mg / 2.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-06

Date Granted : 2001-03-06

blank

10

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Perindopril Arginine, Indapamide

Brand Name : ARCOSYL PLUS

Patent Number : 2644467

Filing Date : 2007-02-26

Strength per Unit : 10 mg / 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-02-26

Date Granted : 2011-07-26

blank